Several deregulated growth factor circuits have been described for Ewing sarcoma cells in the literature such as signaling through the insulin-like growth factor I receptor [18], by human gastrin-releasing peptide [19] and basic fibroblast growth factor [20], as well as platelet derived growth factor[21,22]. The gene discussed is FGF2; the disease is Ewing sarcoma.